The Orthopaedic Implant Company Launches Intramedullary Femur Nail System

RENO, Nev.–(BUSINESS WIRE)–The Orthopaedic Implant Company (OIC) announced the launch of its
Antegrade/Retrograde Intramedullary Femur Nail (ARFN) System today.

The OIC ARFN Nail System is designed to treat femoral midshaft and
distal fractures, providing for both retrograde and antegrade approaches
in one implant design. The nail is available in diameters of 10.0mm
through 13.0mm and lengths of 300mm to 440mm. The nails feature a
1.5-meter bow for anatomic fit and 5.0mm diameter cross-lock screws for
optimal implant fixation. A full carbon-fiber targeter provides for
unobstructed views under fluoroscopy.

The OIC ARFN Nail is part of OIC’s high value IM Nail System and uses
the same instrumentation as all IM nails from OIC. This is the second IM
nail launched by OIC this year. Steve Lichtenthal, VP of Business
Development, said of the launch, “The release of the OIC IM Nail line
has been incredibly timely for our customers as they move to value-based
clinical delivery systems. The OIC Femur Nail broadens the spectrum of
fractures that can be treated while successfully meeting criteria for
clinical and economic performance-based models of care.”

About Orthopaedic Implant Company: OIC entered the medical device
market in 2010 with an innovative approach to delivering the highest
quality implants at the lowest possible prices. OIC implants cost 50 to
60 percent less than the average market price of premium implants,
saving health care systems millions of dollars a year. OIC’s
high-quality, low-cost implants and products can be used for a variety
of procedures, including treatment of orthopaedic trauma and spinal
injuries. All OIC products are FDA approved and manufactured in FDA
approved facilities.


Orthopaedic Implant Company
Steve Lichtenthal, 775-636-8281